{"transactions":[{"id":795408,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2026-05-01T20:11:03.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted pursuant to the Company's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":2.82,"expiration_date":"2036-05-01","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001705562-26-000002","document":"form4-05012026_080500.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000170556226000002/form4-05012026_080500.xml","form_type":"4"}},{"id":1031143,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2025-09-29T20:13:47.000Z","date":"2025-09-25","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 25, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":3.92,"expiration_date":"2035-09-25","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001104659-25-094487","document":"tm2527377-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925094487/tm2527377-2_4seq1.xml","form_type":"4"}},{"id":1397831,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2024-09-30T22:35:31.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":34900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 26, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":34900,"derivative":{"exercise_price":6.81,"expiration_date":"2034-09-26","underlying":"Common Stock, par value $0.0001","underlying_shares":34900},"source":{"system":"sec-edgar","filing":"0001104659-24-104442","document":"tm2425266-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924104442/tm2425266-6_4seq1.xml","form_type":"4"}},{"id":1771443,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2023-09-29T21:01:42.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":26100,"derivative":{"exercise_price":2.5,"expiration_date":"2033-09-28","underlying":"Common Stock, par value $0.0001","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001104659-23-105399","document":"tm2327241-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923105399/tm2327241-6_4seq1.xml","form_type":"4"}},{"id":2148629,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2022-10-01T01:20:19.000Z","date":"2022-09-29","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 29, 2022, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":23500,"derivative":{"exercise_price":12.62,"expiration_date":"2032-09-29","underlying":"Common Stock, par value $0.0001","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001104659-22-104775","document":"tm2227177-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465922104775/tm2227177-1_4seq1.xml","form_type":"4"}},{"id":2559780,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2021-09-25T00:46:26.000Z","date":"2021-09-23","kind":"grant","acquired":true,"shares":24100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 23, 2021, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":24100,"derivative":{"exercise_price":15.44,"expiration_date":"2031-09-23","underlying":"Common Stock, par value $0.0001","underlying_shares":24100},"source":{"system":"sec-edgar","filing":"0001104659-21-119484","document":"tm2128463-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465921119484/tm2128463-3_4seq1.xml","form_type":"4"}},{"id":2825952,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2021-03-02T00:00:23.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":6000,"price":16.08,"value":96480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.68 to $16.56, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":8731,"source":{"system":"sec-edgar","filing":"0000899243-21-008691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924321008691/doc4.xml","form_type":"4"}},{"id":2960468,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-12-03T00:05:12.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":1227,"price":13.54,"value":16613.58,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.51 to $13.59, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares of Common Stock are owned directly by Redmont Venture Partners, Inc.  The reporting person has sole voting and dispositive control with respect to all securities held by Redmont Venture Partners, Inc. and may be deemed to be the beneficial owner of the securities held by Redmont Venture Partners, Inc. The reporting person disclaims beneficial ownership of the securities held by Redmont Venture Partners, Inc. except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-032576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320032576/doc4.xml","form_type":"4"}},{"id":2960467,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-12-03T00:05:12.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":2500,"price":12,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":14731,"source":{"system":"sec-edgar","filing":"0000899243-20-032576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320032576/doc4.xml","form_type":"4"}},{"id":3005069,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (\"RSUs\")","published_at":"2020-10-16T23:00:09.000Z","date":"2020-09-24","kind":"exercise","acquired":false,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16850},"source":{"system":"sec-edgar","filing":"0000899243-20-028535","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320028535/doc4.xml","form_type":"4"}},{"id":3005068,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2020-10-16T23:00:09.000Z","date":"2020-09-24","kind":"exercise","acquired":true,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36306,"source":{"system":"sec-edgar","filing":"0000899243-20-028535","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320028535/doc4.xml","form_type":"4"}},{"id":3021647,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2020-09-28T22:00:39.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":25500,"derivative":{"exercise_price":12.03,"expiration_date":"2030-09-24","underlying":"Common Stock, par value $0.0001","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0000899243-20-026415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320026415/doc4.xml","form_type":"4"}},{"id":3097468,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (\"RSUs\")","published_at":"2020-06-30T01:53:19.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":16850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date."}],"balance_after":16850,"derivative":{"underlying":"Common Stock","underlying_shares":16850},"source":{"system":"sec-edgar","filing":"0000899243-20-017833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000089924320017833/doc4.xml","form_type":"4"}},{"id":3703677,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2019-01-04T22:15:15.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001012975-19-000037","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000101297519000037/edgar.xml","form_type":"4"}},{"id":4184993,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":172442,"kind":"person","name":"Redmont VAXN Capital Holdings, LLC","position":2,"cik":"0001705638","reported_name":"Redmont VAXN Capital Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2017-10-17T20:04:36.000Z","date":"2017-10-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Held by Philip Hodges."}],"balance_after":20000,"derivative":{"exercise_price":2.5,"exercise_date":"2018-04-30","expiration_date":"2027-10-13","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001012975-17-000759","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705638/000101297517000759/edgar.xml","form_type":"4"}},{"id":4184992,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":172442,"kind":"person","name":"Redmont VAXN Capital Holdings, LLC","position":2,"cik":"0001705638","reported_name":"Redmont VAXN Capital Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-10-17T20:04:36.000Z","date":"2017-10-17","kind":"other","acquired":false,"shares":1278471,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Redmont VAXN Capital Holdings, LLC, a Delaware limited liability company (\"Redmont VAXN\") distributed to its members, pro rata and without consideration, 1,278,471 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of shares of Common Stock held by Redmont VAXN. Philip Hodges has sole voting and dispositive control with respect to all securities held by Redmont VAXN. Philip Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001012975-17-000759","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705638/000101297517000759/edgar.xml","form_type":"4"}},{"id":4330261,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":172442,"kind":"person","name":"Redmont VAXN Capital Holdings, LLC","position":2,"cik":"0001705638","reported_name":"Redmont VAXN Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176393,"kind":"organization","name":"Redmont Venture Partners, Inc.","position":3,"cik":"0001705639","reported_name":"Redmont Venture Partners, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176392,"kind":"organization","name":"Paradigm Venture Partners, L.P.","position":4,"cik":"0001705640","reported_name":"Paradigm Venture Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-05-08T20:37:18.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":4455,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement, the then outstanding shares of Altimmune's capital stock was converted into the right to receive a number of shares of the Issuer's common stock, par value $0.0001 on a 0.749106:1 basis upon the closing of the merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Consists of shares of Common Stock held by Paradigm Venture Partners, L.P., a Delaware limited partnership (\"PVP\").  Mr. Hodges has sole voting and dispositive control with respect to all securities held by PVP. Mr. Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."}],"balance_after":4455,"source":{"system":"sec-edgar","filing":"0000899243-17-012362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705638/000089924317012362/doc4.xml","form_type":"4"}},{"id":4330260,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":172442,"kind":"person","name":"Redmont VAXN Capital Holdings, LLC","position":2,"cik":"0001705638","reported_name":"Redmont VAXN Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176393,"kind":"organization","name":"Redmont Venture Partners, Inc.","position":3,"cik":"0001705639","reported_name":"Redmont Venture Partners, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176392,"kind":"organization","name":"Paradigm Venture Partners, L.P.","position":4,"cik":"0001705640","reported_name":"Paradigm Venture Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-05-08T20:37:18.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":36785,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement, the then outstanding shares of Altimmune's capital stock was converted into the right to receive a number of shares of the Issuer's common stock, par value $0.0001 on a 0.749106:1 basis upon the closing of the merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Consists of shares of Common Stock held by Redmont Venture Partners, Inc., a Delaware corporation (\"RVP\").  Mr. Hodges has sole voting and dispositive control with respect to all securities held by RVP.  Mr. Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."}],"balance_after":36785,"source":{"system":"sec-edgar","filing":"0000899243-17-012362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705638/000089924317012362/doc4.xml","form_type":"4"}},{"id":4330259,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50270,"kind":"person","name":"Hodges Philip","position":1,"cik":"0001705562","reported_name":"Hodges Philip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":172442,"kind":"person","name":"Redmont VAXN Capital Holdings, LLC","position":2,"cik":"0001705638","reported_name":"Redmont VAXN Capital Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176393,"kind":"organization","name":"Redmont Venture Partners, Inc.","position":3,"cik":"0001705639","reported_name":"Redmont Venture Partners, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":176392,"kind":"organization","name":"Paradigm Venture Partners, L.P.","position":4,"cik":"0001705640","reported_name":"Paradigm Venture Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2017-05-08T20:37:18.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":1278471,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement, the then outstanding shares of Altimmune's capital stock was converted into the right to receive a number of shares of the Issuer's common stock, par value $0.0001 on a 0.749106:1 basis upon the closing of the merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of shares of Common Stock held by Redmont VAXN Capital Holdings, LLC, a Delaware limited liability company (\"RVCH\").  Philip Hodges has sole voting and dispositive control with respect to all securities held by RVCH.  Mr. Hodges disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein."}],"balance_after":1278471,"source":{"system":"sec-edgar","filing":"0000899243-17-012362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705638/000089924317012362/doc4.xml","form_type":"4"}}]}